SWOG S0709: Randomized phase II trial of erlotinib versus erlotinib plus carboplatin/paclitaxel in patients with advanced non-small cell lung cancer and impaired performance status as selected by a serum proteomics assay

Primo N. Lara, James Moon, Paul J. Hesketh, Mary W. Redman, Stephen K. Williamson, Wallace L. Akerley, Fred R. Hirsch, Philip C. Mack, David R. Gandara

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'SWOG S0709: Randomized phase II trial of erlotinib versus erlotinib plus carboplatin/paclitaxel in patients with advanced non-small cell lung cancer and impaired performance status as selected by a serum proteomics assay'. Together they form a unique fingerprint.

Medicine & Life Sciences